Oct
19
HGH & Old Age Symptoms
October 19, 2009 | Leave a Comment
The chances are that you’ve already heard about the many remarkable benefits with regards to taking HGH supplements, so let’s take a good look at each of these benefits in greater detail so that you know what results you can expect to achieve.
First of all, as people begin to age, various body functions begin deteriorating. For example, eyesight is no longer as good as it once was, your memory may begin failing you at times, wrinkles start appearing, and your hearing often becomes a problem. So, let’s go ahead and take a look at how the benefits of HGH supplements can help reverse some of these age-related symptoms. When one considers the numerous benefits of increasing HGH levels, it becomes apparent just how effective this hormone can be in terms of affecting the way we think, feel, and look. Essentially, HGH supplements can be extremely beneficial in helping you to manage and cope with a number of age related problems. Considering just how many benefits there are with regards to taking HGH supplements, it only stands to reason that we should consider taking them on a regular basis.
Aug
13
Prolor Biotech to Use The University of Queensland’s Human Growth Hormone (HGH) Cell Line
August 13, 2009 | Leave a Comment
Prolor Biotech obtained a nonexclusive license to The University of Queensland’s (UQ) human growth hormone (HGH) receptor cell line. It will help the company expedite development and manufacturing of its long-acting version of HGH, comments Shai Novik, president of Prolor Biotech.
“Not only can the cell line measure the hormone’s potency, but it can also be used to detect neutralizing antibodies directed against HGH,†Novik points out. The UQ cell line will also result in significant cost savings, provide more reliable and consistent results compared to current techniques, and does not require animals for testing, the company continues.
Current manufacturers of human growth hormone assay for potency by using hypophysectomized rodents. HGH is then administered to the animals and the potency determined by measuring their weight gain and length of femur. This assay is not only extremely expensive but also produces inconsistent results, according to Prolor Biotech.
Jul
1
FDA Approves HGH Needle Free Device
July 1, 2009 | Leave a Comment
The FDA issued approval for Antares Pharma’s (Ewing, New Jersey) needle-free injection device for use with Tev-Tropin brand human growth hormone (hGH) from Teva out of Petach Tikva, Israel. The device will be marketed under the name Tev-Tropin Tjet Injector system.
 Reusable Needle-Free Injectors (Medi-Jector VISION®) deliver precise medication doses through high-speed, pressurized liquid penetration of the skin without a needle. These reusable, variable-dose devices are engineered to last for a minimum of two years and are designed for easy use, facilitating self-injection with a disposable plastic needle-free syringe to assure safety and efficacy. The associated disposable plastic needle-free syringe, offers high precision liquid medication delivery through an opening that is approximately half the diameter of a standard, 30-gauge needle and it is designed to last for approximately one week. Antares has sold the Medi-Jector VISION® for use in more than 30 countries to deliver either insulin or human growth hormone (”hGH”).
                 Â
Check out what others are saying about a safe alternative to real HGH injections! Click here!
Mar
26
Frost & Sullivan Accolade for Ferring Pharmaceuticals/HGH
March 26, 2009 | Leave a Comment
LONDON, March 25, 2009 /PRNewswire via COMTEX/ —-The 2008 Frost & Sullivan European Human Growth Hormone Competitive Strategy Leadership Award is presented to Ferring Pharmaceuticals.
The award is in recognition of Ferring’s initiatives in providing no-needle injection for human growth hormone (hGH). The company offers ZOMAJET 2 VISION and ZOMAJET VISION X, innovative no-needle delivery systems for its human growth hormone, ZOMACTON.Â
These novel, no-needle delivery systems are poised to help Ferring to not only sustain its market share in the European growth hormones market, but also to expand its presence in the hGH market worldwide.
“Drug delivery systems provide strategic differentiation to successfully increase sales for companies established in the hGH market,” notes Frost & Sullivan Research Analyst Prabakar Sampath. “Through its innovation in no-needle devices, and clinical evidence showing the high level of childrens’ preference for no-needle hGH administration, Ferring has shown leadership in meeting the needs of the paediatric population in this therapy area. “
Read the entire Ferring Pharmaceuticals/HGH article
Oct
17
China Pharmaceutical Company Expanding For More HGH Production
October 17, 2008 | Leave a Comment
GeneScience Pharmaceuticals Co., Ltd. (GenSci), one of China’s leading biopharmaceuticals producers (including hgh), recently started the construction of its new medicine of genetic engineering base in the Changchun High-tech Industrial Development Area, Jilin Province, Northeast China.
In the near future, this base will be created as the nation’s largest and most profitable genetic engineering pharmacy center with ten pillar products, including recombinant human growth hormone (hgh), thymosin, and follicle stimulating hormone. Its sales revenue is likely to reach CNY 2 billion to CNY 5 billion within the following five to eight years, said insiders.
Want to learn more about a safe alternative to real hgh? Click here.
Oct
16
EMD Serono Recipient of R&D 100 Award For Easypod HGH Device
October 16, 2008 | Leave a Comment
Easypod was recently recognized as one of the most technologically significant innovations of the year.
Easypod, a first-of-its-kind prescription device for the administration of Saizen® [somatropin (rDNA origin) for injection] human growth hormone (hgh) therapy, is announced as the winner of an R&D 100 Award for its breakthrough technology. Hailed as “The Oscars of Invention†by The Chicago Tribune, the R&D 100 Awards have honored the 100 most technologically significant innovations each year, since 1963. Along with other recipients, easypod was recognized in a special September issue of R&D Magazine and will be recognized at a banquet on October 16, in Chicago. Easypod was nominated for its innovative technology that answers the need for a device that provides simple everyday use.
Is there an alternative to hgh that is safe, effective, and LEGAL? Yes! Click here for details!
Sep
24
Novo Nordisk Developing Long-Acting HGH
September 24, 2008 | Leave a Comment
BAGSVAERD, DENMARK, Sep 26, 2008 (MARKET WIRE via COMTEX) — Novo Nordisk provides update on corporate strategy at its Capital Markets Day.
Within the area of human growth hormone, Novo Nordisk will present its plans for label expansions as well as the clinical progress for a long-acting human growth hormone (HGH)Â compound which is currently in phase 2 clinical development. The phase 3 study for the use of Norditropin(R) for the treatment of dialysis patients is now expected to be completed in 2012 due to slower than anticipated recruitment of patients.
Jul
28
HGH Injections To Be Needle Free
July 28, 2008 | Leave a Comment
 Needle free HGH coming soon:
Antares Pharma, Inc. (Amex: AIS), a Ewing-based specialty pharmaceutical company focused on drug delivery, and its partner Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) of North Wales, Pa., announced today that they have sought regulatory approval to administer their human-growth hormone (HGH) with needle-free injections.
Human-growth hormone (HGH)Â is commonly used to treat children of pathologically short stature, according to the companies. Pediatric patients and their parents that assist in administering such drugs can benefit from the “elimination of needles and disposal of contaminated sharps,” they said.
Antares and Teva filed a “supplemental New Drug Application” with the U.S. Food and Drug Administration for labeling changes to reflect the needle-free injection route after conducting 18 months of clinical tests and studies, they stated. They said that, according to industry estimates, the size of the U.S. market for human-growth hormones (HGH)Â is about $1 billion.
May
29
 Biosimilair versions of HGH recently received approval in Europe.
LONDON - With the first generic biologics reaching the market in Europe, the focus has shifted from arguments about how to approve them, to how the products should be used in clinical practice.
Rather than biogenerics, the European Medicines Agency (EMEA) has tagged the products as biosimilars. The explicit recognition that they are not exactly the same as the originator product is raising issues of substitutability and pharmacovigilance.
Two biosimilar versions of erythropoietin (EPO) and two of somatrophin (human growth hormone) have been approved, a G-CSF biogeneric is about to get the nod and there will be many more products on the market in the next five years, making it essential that processes are in place to ensure their safe and appropriate use.
Apr
21
50,000 Physicians & Scientists On HGH, Other Remedies
April 21, 2008 | Leave a Comment
50,000 physicians and scientists from 96 worldwide educational affiliates in anti-aging and regenerative medicine urge emergency action to counter a calculated campaign, lacking in scientific basis and brimming with political motivations, against hormone therapies including HGH,  nutritional medicine, and compounding pharmacies. Here is an excerpt from the PRWeb article:
For the first time in the history of the United States, Congress is allowing non-physicians to dictate the indications for a drug, effectively eliminating and criminalizing the physicians’ sovereign right to prescribe according to conscience. Misguided and potentially dangerous pending Congressional legislation aims to ban the American public’s access to nutrients, drugs, and hormone therapies like HGH and retard the advancement of preventive healthcare in the United States by a decade or more. Â
Hormone therapies (including Adult Growth Hormone Replacement Therapy,HGH, and Bio-Identical Hormone Replacement Therapy), nutritional medicine, and compounding pharmacies serve an important role in improving both the quality and quantity of life in millions of Americans today.
Stop the unjust crirminalization of physician prescribed hormone replacement therapies and nutritional medicine. There are no villains or evil-doers in the community of law abiding patients and their caring and compassionate physicians and pharmacists who are dedicated to keeping American men and women healthy, vital, and in optimal physical and mental performance throughout advancing age.
Read what a doctor has to say about the HGH product she uses.
keep looking »Recommended Links
GET YOUR FREE HGH &
ANTI-AGING REPORT!
- Get your own FREE copy of the groundbreaking report, "Seven Age Reversing Secrets" – packed with valuable tips and tricks to help you fight the aging process and have the highest quality of life possible!